Joscha Borho, Merle Kögel, Amelie Eckert, & Holger Barth. (2024). Repurposing FDA-approved disulfiram for targeted inhibition of diphtheria toxin and the binary protein toxins of Clostridium botulinum and Bacillus anthracis. Frontiers Media S.A..
Chicago Style (17th ed.) CitationJoscha Borho, Merle Kögel, Amelie Eckert, and Holger Barth. Repurposing FDA-approved Disulfiram for Targeted Inhibition of Diphtheria Toxin and the Binary Protein Toxins of Clostridium Botulinum and Bacillus Anthracis. Frontiers Media S.A., 2024.
MLA (9th ed.) CitationJoscha Borho, et al. Repurposing FDA-approved Disulfiram for Targeted Inhibition of Diphtheria Toxin and the Binary Protein Toxins of Clostridium Botulinum and Bacillus Anthracis. Frontiers Media S.A., 2024.
Warning: These citations may not always be 100% accurate.